[Improved expression of HLA-A* 2402-BSP in Escherichia coli and its tetramer preparation].

Sheng Wu Gong Cheng Xue Bao

Institute of Tissue Transplantation and Immunology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.

Published: March 2007

AI Article Synopsis

  • HLA-A* 2402 is a common type of HLA-A allele in East Asian populations, and this study focuses on using it to investigate CD8+ T cell responses in Chinese individuals.
  • Researchers created a specific tetramer loaded with a peptide from HCMV (QYDPVAALF) to analyze T cell responses, cloning the necessary HLA-A* 2402 heavy chain and optimizing its expression in E. coli.
  • The generated tetramer showed binding activity to cytotoxic T lymphocytes (CTL) from individuals with HLA-A* 2402, allowing for insights into immune responses against HCMV in these populations.

Article Abstract

HLA-A* 2402 is one of the most frequently encountered HLA-A alleles in East Asian populations. In order to study the CD8+ T cell responses in Chinese populations, we have described the generation and functional test of HLA-A* 2402 tetramer loaded with HCMV pp65(341-349) peptide (QYDPVAALF, QYD). The cDNA of HLA-A* 2402 heavy chain was cloned by RT-PCR from one of the donors. DNA fragment encoding the ectodomain of HLA-A* 2402 heavy chain fused at its carboxyl-terminal a BirA substrate peptide (BSP) was amplified by PCR with the cloned heavy chain cDNA as a template. The wild-type gene of HLA-A* 2402-BSP was not expressed in Escherichia coli (E. coli), while mutant HLA-A* 2402-BSP gene with optimized codons was overexpressed as inclusion bodies in E. coli. Furthermore, the soluble HLA-A* 2402-QYD monomers were generated by in vitro refolding of washed inclusion bodies in the presence of beta2-microglobulin and QYD peptide. The tetramer was subsequently formed by mixing HLA-A* 2402-QYD monomers with streptavidin-PE at a molar ratio of 4:1. Flow cytometry analysis indicated that this tetramer possessed binding activity with specific CTL from HLA-A24+ donors and the frequencies of tetramer-binding CTL were 0.09% - 0.37% within total CD8+ T cells. This tetrameric agent provides a powerful tool to explore the secrets of CTL responses against HCMV antigens in HLA-A* 2402 individuals.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1872-2075(07)60025-9DOI Listing

Publication Analysis

Top Keywords

hla-a* 2402
20
hla-a* 2402-bsp
12
heavy chain
12
hla-a*
10
escherichia coli
8
2402 heavy
8
inclusion bodies
8
hla-a* 2402-qyd
8
2402-qyd monomers
8
0
5

Similar Publications

The adoptive transfer of TCR-T cells specific to neoantigens preferentially exhibits potent cytotoxicity to tumor cells and has shown promising efficacy in various preclinical human cancers. In this study, we first identified a functional TCR, Tcr-1, which selectively recognized the SYT-SSX fusion neoantigen shared by most synovial sarcomas. Engineered T-cell expressing Tcr-1 (Tcr-T1) demonstrated HLA-A*2402-restricted, antigen-specific anti-tumoral efficacy against synovial sarcoma cells, both in vitro and in vivo.

View Article and Find Full Text PDF
Article Synopsis
  • - HTLV-1 can quickly transform CD4+ T cells in a lab setting, but most infected people remain asymptomatic, indicating a balance between the virus and the host's immune response.
  • - The study found a variant in the HTLV-1 Tax301-309 viral antigen in individuals with a specific HLA-A24 type, which affected the detection of anti-Tax cytotoxic T cells (CTLs).
  • - More than half of the T-cell receptors (TCRs) from these anti-Tax CTLs failed to recognize the mismatched Tax301-309 peptides, underlining the need for precise matching of viral antigens in T-cell therapy for adult T-cell leukemia (ATL).
View Article and Find Full Text PDF

HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.

Int J Mol Sci

June 2024

Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.

Increased human T-cell leukemia virus type 1 (HTLV-1) proviral load (PVL) is a significant risk factor for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is controversy surrounding whether HTLV-1-specific cytotoxic T lymphocytes (CTLs) are beneficial or harmful to HAM/TSP patients. Recently, HTLV-1 Tax 301-309 has been identified as an immunodominant epitope restricted to HLA-A*2402.

View Article and Find Full Text PDF

Objective: The objective is to describe the HLA allelic frequency in PsA and correlate it with demographic and clinical variables.

Methods: Retrospective study of adult patients with a diagnosis of PsA (n=23) and healthy controls (n=46), all with a request for HLA-A, B, C, DR. Typing was performed using HLA-PCR/SSO LifeCodes and analyzed on the LUMINEX IS100/200 xMAP system.

View Article and Find Full Text PDF

As the MHC-I-pathway is key to antigen presentation to cytotoxic T-cells and, therefore, recognition by the host adaptive immune system, we hypothesized that SARS-CoV-2 including its Variants of Concern (VOCs), influences MHC-I expression on epithelial cell surfaces as an immune evasion strategy. We conducted an in vitro time course experiment with the human airway epithelial cell line Calu-3 and the human colorectal adenocarcinoma cell line Caco-2. Cells were infected with SARS-CoV-2 strains non-VOC/B.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!